A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Phase of Trial: Phase II
Latest Information Update: 25 May 2017
At a glance
- Drugs Santalum album (Primary)
- Indications Warts
- Focus Therapeutic Use
- Sponsors ViroXis
- 03 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 13 Dec 2013 Planned end date changed from 1 Jul 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov record.